Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients-Reference-Cited by-同舟云学术

Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients

Published:2018-01-22 Issue:8 Volume:24 Page:1866-1871
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Drögemöller Britt I.,Brooks Beth,Critchley Carol,Monzon José G.,Wright Galen E.B.,Liu Geoffrey,Renouf Daniel J.,Kollmannsberger Christian K.,Bedard Philippe L.,Hayden Michael R.,Gelmon Karen A.,Carleton Bruce C.,Ross Colin J.D.

Funder

CIHR

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy;Cancer Medicine;2024-08

2. Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update;Therapeutic Drug Monitoring;2023-07-13

3. Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study;Cancers;2023-03-14

4. Systematic Review and Meta‐analysis of the Influence of Genetic Variation on Ototoxicity in Platinum‐Based Chemotherapy;Otolaryngology–Head and Neck Surgery;2023-02-17

5. Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia;Frontiers in Pharmacology;2023-01-09